T1	Procedure 38 55	histopathological
E1	Procedure:T1 
T2	Or 56 58	or
E2	Or:T2 
T3	Procedure 59 82	cytological examination
E3	Procedure:T3 Name:T46
T4	Eq-Comparison 136 148	at least one
E4	Eq-Comparison:T4 Operator:T47 Value:T48
T5	Condition 149 165	evaluable lesion
E5	Condition:T5 Name:T49
T6	Eq-Comparison 215 223	received
E6	Eq-Comparison:T6 Temporal-Period:T50
T7	Procedure 224 239	local treatment
E7	Procedure:T7 
T8	Eq-Comparison 278 297	previously received
E8	Eq-Comparison:T8 Temporal-Period:T51 Temporal-Period:T52
T9	Modifier 298 313	anti-programmed
E9	Modifier:T9 
T10	Procedure 314 330	death receptor-1
E10	Procedure:T10 
T11	Drug 332 336	PD-1
E11	Drug:T11 Name:T54
T12	Modifier 338 346	antibody
E12	Modifier:T12 
T13	Modifier 348 363	anti-programmed
E13	Modifier:T13 
T14	Drug 370 378	ligand-1
E14	Drug:T14 Name:T55
T15	Observation 380 385	PD-L1
E15	Observation:T15 Name:T56 Name:T57
T16	Modifier 387 395	antibody
E16	Modifier:T16 
T17	Condition 397 427	anti-programmed death ligand-2
E17	Condition:T17 
T18	Observation 429 434	PD-L2
E18	Observation:T18 Name:T60 Name:T61
T19	Modifier 436 444	antibody
E19	Modifier:T19 
T20	Or 445 447	or
E20	Or:T20 
T21	Modifier 448 475	anti-cytotoxic T lymphocyte
E21	Modifier:T21 
T22	Drug 498 504	CTLA-4
E22	Drug:T22 Name:T63
T23	Drug 506 516	antibodies
E23	Drug:T23 Name:T64
T24	Study 576 581	study
E24	Study:T24 
T25	Eq-Comparison 601 620	previously received
E25	Eq-Comparison:T25 Temporal-Period:T65
T26	Procedure 625 629	TACE
E26	Procedure:T26 Name:T66
T27	Procedure 631 654	radiofrequency ablation
E27	Procedure:T27 Name:T67
T28	And 655 658	and
E28	And:T28 
T29	Other 659 664	other
E29	Other:T29 
T30	Procedure 665 688	liver cancer treatments
E30	Procedure:T30 
T31	Eq-Comparison 711 718	history
E31	Eq-Comparison:T31 Temporal-Period:T69
T32	Condition 722 746	gastroesophageal varices
E32	Condition:T32 Name:T70
T33	Or 747 749	or
E33	Or:T33 
T34	Eq-Comparison 750 756	active
E34	Eq-Comparison:T34 Temporal-Period:T71
T35	Condition 757 770	cardia ulcers
E35	Condition:T35 Name:T72
T36	Risk 794 798	risk
E36	Risk:T36 
T37	Condition 802 810	bleeding
E37	Condition:T37 Name:T74
T38	Condition 835 868	upper gastrointestinal hemorrhage
E38	Condition:T38 Name:T75
T39	Eq-Comparison 869 882	within 1 year
E39	Eq-Comparison:T39 Operator:T76 Value:T77 Temporal-Unit:T78
T40	Condition 912 929	fibrous layer HCC
E40	Condition:T40 Name:T79
T41	Condition 931 946	sarcomatoid HCC
E41	Condition:T41 Name:T80
T42	Or 947 949	or
E42	Or:T42 
T43	Condition 956 974	cholangiocarcinoma
E43	Condition:T43 Name:T81
T44	Condition 979 982	HCC
E44	Condition:T44 Name:T82
T45	Other 984 989	Other
E45	Other:T45 
T46	Procedure-Name 59 82	cytological examination
T47	Eq-Operator 136 144	at least
A1	Eq-Operator-Value T47 GTEQ
T48	Eq-Value 145 148	one
T49	Condition-Name 159 165	lesion
T50	Eq-Temporal-Period 215 223	received
A2	Eq-Temporal-Period-Value T50 past
T51	Eq-Temporal-Period 278 288	previously
A3	Eq-Temporal-Period-Value T51 past
T52	Eq-Temporal-Period 289 297	received
A4	Eq-Temporal-Period-Value T52 past
T53	Drug-Name 320 330	receptor-1
T54	Drug-Name 332 336	PD-1
T55	Drug-Name 370 378	ligand-1
T56	Observation-Name 380 382	PD
A5	Observation-Type-Value T56 lab
T57	Observation-Name 383 385	L1
A6	Observation-Type-Value T57 lab
T58	Drug-Name 397 412	anti-programmed
T59	Drug-Name 419 427	ligand-2
T60	Observation-Name 429 431	PD
A7	Observation-Type-Value T60 lab
T61	Observation-Name 432 434	L2
A8	Observation-Type-Value T61 lab
T62	Drug-Name 448 475	anti-cytotoxic T lymphocyte
T63	Drug-Name 498 504	CTLA-4
T64	Drug-Name 506 516	antibodies
T65	Eq-Temporal-Period 601 620	previously received
A9	Eq-Temporal-Period-Value T65 past
T66	Procedure-Name 625 629	TACE
T67	Procedure-Name 631 654	radiofrequency ablation
T68	Condition-Name 671 677	cancer
T69	Eq-Temporal-Period 711 718	history
A10	Eq-Temporal-Period-Value T69 past
T70	Condition-Name 722 746	gastroesophageal varices
T71	Eq-Temporal-Period 750 756	active
A11	Eq-Temporal-Period-Value T71 present
T72	Condition-Name 757 770	cardia ulcers
T73	Polarity 789 793	high
A12	Polarity-Value T73 high
T74	Condition-Name 802 810	bleeding
T75	Condition-Name 858 868	hemorrhage
T76	Eq-Operator 869 875	within
A13	Eq-Operator-Value T76 LTEQ
T77	Eq-Value 876 877	1
T78	Eq-Temporal-Unit 878 882	year
A14	Eq-Temporal-Unit-Value T78 year
T79	Condition-Name 912 929	fibrous layer HCC
T80	Condition-Name 931 946	sarcomatoid HCC
T81	Condition-Name 956 974	cholangiocarcinoma
T82	Condition-Name 979 982	HCC
